首页> 美国卫生研究院文献>Acta Pharmaceutica Sinica. B >Serum and glucocorticoid inducible protein kinases (SGKs): a potential target for cancer intervention
【2h】

Serum and glucocorticoid inducible protein kinases (SGKs): a potential target for cancer intervention

机译:血清和糖皮质激素诱导型蛋白激酶(SGK):癌症干预的潜在目标

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The serum and glucocorticoid inducible protein kinase (SGK) family members share similar structure, substrate specificity and function with AKT and signal downstream of the phosphatidylinositol 3-kinase (PI3K) signalling pathway. They regulate a range of fundamental cellular processes such as cell proliferation and survival, thereby playing an important role in cancer development. This perspective intends to give an overview on the involvement of SGKs (particularly SGK3) in cancer progression, and compares the actions of SGK3 and AKT in cell cycle regulation, oncogenic signalling, and the potential as a therapeutic target for cancer.
机译:血清和糖皮质激素诱导蛋白激酶(SGK)家族成员与AKT具有相似的结构,底物特异性和功能,并在磷脂酰肌醇3激酶(PI3K)信号传导途径的下游发出信号。它们调节一系列基本的细胞过程,例如细胞增殖和存活,从而在癌症发展中发挥重要作用。该观点旨在概述SGK(特别是SGK3)参与癌症进展,并比较SGK3和AKT在细胞周期调节,致癌信号传导中的作用以及作为癌症治疗靶标的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号